School of Medicine
Showing 1-10 of 52 Results
Laura Michele Hack
Clinical Instructor, Psychiatry and Behavioral Sciences
Bio Dr. Laura Hack is a Postdoctoral Fellow and Clinical Instructor under the mentorship of Drs. Leanne Williams, Alan Schatzberg, and Ruth O?Hara. She is a translational clinician with a research passion for integrating multiple types of biological and environmental data using advanced analytic techniques into a neuroscience-based taxonomy of mood, anxiety, and stressor-related disorders. Laura envisions herself as a ?psychiatrist of the future,? incorporating genetic information, brain imaging, blood-based markers, and data from wearable sensors into diagnostic and treatment decisions to help relieve the suffering that arises from our current trial-and-error approach.
Scott S. Hall, Ph.D
Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences) at the Stanford University Medical Center
Current Research and Scholarly Interests My primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.
Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Principal Investigator
Infrastructure to facilitate discovery of autism genes
The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.
A California Population-Based Twin Study of Autism
This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?
Center for Integrating Ethics in Genetics Research(Cho)
The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.
Gene, Brain and Behavior in Turner Syndrome(Reiss)
The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.
Project F: Genomic Analysis in narcolepsy cataplexy
The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families.
Casey H. Halpern, MD
Assistant Professor of Neurosurgery and, by courtesy, of Neurology and of Psychiatry and Behavioral Sciences at the Stanford University Medical Center
Current Research and Scholarly Interests We are currently investigating the effects of deep brain stimulation in obesity using mouse models of human behavior. Many obese individuals exhibit behavioral disinhibition, a clinical feature of many neurologic and psychiatric conditions. We are dissecting the mesocorticolimbic circuit with novel techniques including optogenetics.
Maryam Sarah Hamidi
Soc Science Rsch Prof 3, Psych/General Psychiatry and Psychology (Adult)
Current Role at Stanford Associate Director of Scholarship & Health Promotion at Stanford Medicine WellMD Center
Research Professional at Department of Psychiatry and Behavioral Sciences
Public Rel Offcr 2, Psychiatry and Behavioral Sciences
Current Role at Stanford Web & Communications Administration
Psychiatry and Behavioral Sciences (http://med.stanford.edu/psychiatry.html)
Postdoctoral Research Fellow, Psychiatry
Bio Sahar Harati, Ph.D., graduated with a PhD in Biomedical Informatics from Emory University. She received her Master?s degree in Computer Science from the same university and her Bachelor?s degree in Software Engineering from Sharif University of Technology in Iran. Her research interests are broadly Machine Learning and Data Mining with applications to Mental Health and Biomedical Informatics. For her thesis, she utilized advanced signal processing and machine learning techniques to study longitudinal data collected from patients recovering from Major Depressive Disorder when treated by Deep Brain Stimulation. Her research goal is to improve human mental well-being by developing computational techniques to find objective biomarkers of depression. She joined PanLab to work on interdisciplinary projects to develop predictive models of depression from physiological and behavioral measures.
Antonio Hardan, M.D.
Professor of Psychiatry and Behavioral Sciences at the Stanford University Medical Center
Current Research and Scholarly Interests The neurobiology of autism
Neuroimaging in individuals with autism
Psychopharmacological treatment of children and adults with autism and/or developmental disorders
The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations).